Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
GPS Killer: Google Rules Another Roost
by Ryan Cole, Investment U Research
Google just changed everything… again.
The rumor that Google Inc. (Nasdaq: GOOG) might offer turn-by-turn GPS navigation has just turned into a reality, as the tech giant brought the feature to all Android 2.0 devices. For free.
Beginning September 17th, Google’s stock has jumped over 10%… while Garmin (Nasdaq: GRMN) has fallen almost 15% and fellow GPS provider TomTom (AMS: TOM) is off a stunning 38%. The latter has fallen 24% today alone.
(Follow all three live here and be sure to check out Engadget as well, since it originally alerted us about this movement.)
The markets have decided: Google just killed stand-alone GPS navigation. After all, why pay $300 for a navigator when you can get it free on your phone?
Of course, not everyone owns an Android phone, and it’s unclear when Google will roll out the feature to other operating systems.
Still, Google has promised such a roll-out in the future for devices with the hardware capable of handling the software. Yes, probably even Apple’s (Nasdaq: AAPL) iPhone along with a few others… eventually.
With the software providing turn-by-turn spoken directions, Google’s street view map and speech recognition – which allows users to simply say their desired destination to get a route – make it a killer app… literally.
It’s unlikely Garmin or TomTom can survive this without some very nimble repositioning.
Let’s be clear: Standalone GPS navigators will likely still have a niche, but it’s fast becoming a very small niche.
As Google rolls this software out to more and more phones – and more and more people buy smartphones – the standalone GPS will quickly lose its power in the consumer market.
In short, get out of Garmin and TomTom. They may bounce back a little from current lows, as investors realize this won’t be an overnight transition. But make no mistake: Both companies are in very big trouble.
Google, meanwhile, continues to expand its dominance of the digital world.
Good investing,
Ryan Cole
- What Investors Need To Know About Android’s Upcoming iPhone “Shuffle.”
- Garmin Ltd. (Nasdaq: GRMN): Stock of the Day
- How Google’s Android is Set to Take a Bite of the Mobile Competition
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed